Back

Associations between antidiabetic drug classes and aortic aneurysm risk in patients with type 2 diabetes: a nationwide cohort study

29 August 2026 (16:33 - 16:45)
Organised by: Logo
Congress Presentation Part of: Aortic diseases: from genomics to general application Aortic Aneurysm, Abdominal ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Ya Wen Lu

Taichung Veterans General Hospital, Taichung (Taiwan)

4 More presentations in this session

Presentation thumbnail
[18F]-FAPI PET/CT delineates FAP expression dynamics and distribution in acute aortic syndrome: clinical prognosis and intervention implications
Doctor S. Wang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Flow displacement and increased circumferential wall shear stress predict ascending aortic dilatation: a prospective 5-year follow-up study
Doctor S. Sillanmaki (Kuopio, FI)
Abstract Slides
Presentation thumbnail
Integrative genomics identifies putative causal genes and therapeutic targets in thoracic aortic disease
Ms J. Horjus (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Clinical impact and genomic profile in patients with nonsyndromic FBN1-related thoracic aortic aneurysm and dissection
Doctor H. Yagi (Tokyo, JP)
Abstract Slides

Access the full session

Session thumbnail
Aortic diseases: from genomics to general application
Video

The Event

Event poster

ESC Congress 2026

29 August 2026 16:33 CET
You may be interested in
thumbnail
Congress Presentation
Association between diabetes mellitus and abdominal aortic aneurysm: a mendelian randomization study
3 September 2019
thumbnail
Congress Presentation
Effects of linagliptin vs glimepiride stratified by prior insulin secretagogue use in the cardiovascular outcome study of linagliptin versus glimepiride in type 2 diabetes (CAROLINA) trial
31 August 2020
thumbnail
Congress Presentation
Metformin reduces the risk of hospitalization for heart failure in type 2 diabetes patients: a retrospective cohort analysis
3 September 2019
thumbnail
Congress Presentation
Patient vascular model reveals anti-inflammatory effects of SGLT2 inhibitor by modulating endothelial-T cell crosstalk
31 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources